Pfizer forecasts 2026 profit below expectations on lower COVID product sales

Core Viewpoint - Pfizer has projected that its profit for 2026 will fall below Wall Street estimates due to anticipated lower sales of its COVID products, resulting in a 1.6% decline in its shares during premarket trading [1] Group 1 - Pfizer's forecast for 2026 profit is lower than Wall Street expectations [1] - The company expects a decrease in sales from its COVID-related products [1] - The announcement led to a 1.6% drop in Pfizer's shares in premarket trading [1]